Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Apr 18, 2023 9:58am
222 Views
Post# 35400363

RE: I have a dream......

RE: I have a dream......Under normal circumstances a company would need to enter a phase of maturity and stable growth generating excess cash to pay out dividends.   Normally before a company achieves that phase of dividend payments, a fast growth company generating strong revenues will normally give their shareholders a stock split during it's fast growth phase.  

However, depending on the structure of the deal LABS and Pfizer agree to, any exchange ratio of Pfizer stock for LABS stock would result in the immediate existence of a divident payment.   One share of Pfizer paid out a dividend of $.41 U.S. on March 3, 2023. 

I have all sorts of dreams as well, waking up at night only to see that my special someone activated the double tap touch sensor on my smart phone screen.   

 
<< Previous
Bullboard Posts
Next >>